[DGTR insights](https://indusdesk.com/dgtr/insights/)

# DGTR recommends anti-dumping duty on Chinese and Thai ethambutol

https://indusdesk.com/dgtr/insights/dgtr-recommends-anti-dumping-duty-on-chinese-and-thai-ethambutol/

The Directorate General of Trade Remedies issued Case No. AD(OI)-22/2025 on September 17, 2026. DGTR's final findings recommend a five-year anti-dumping duty on ethambutol hydrochloride: USD 5,347 to 7,234 per MT from China, USD 6,584 from Thailand. It applies to imports of ethambutol hydrochloride, and ethambutol in its free base form, from China and Thailand.

DGTR · September 17, 2026

Vishnu Gupta

These are the Final Findings of the Directorate General of Trade Remedies (DGTR), Department of Commerce, Ministry of Commerce & Industry, in the anti-dumping investigation concerning imports of "Ethambutol Hydrochloride" originating in or exported from China and Thailand (Case No. AD(OI)-22/2025, F. No. 6/25/2025-DGTR). They are dated September 17, 2026, were published in the Gazette of India, Extraordinary, Part I, Section 1, No. 254, and are signed by Amitabh Kumar, Designated Authority. Lupin Limited applied, and DGTR initiated the investigation on September 23, 2025. DGTR held Lupin to be the domestic industry, with 100% of eligible Indian production. It did not count Cadila Pharmaceuticals as an eligible producer, because its imports were significant in relation to its installed capacity.

The product is ethambutol hydrochloride, a bacteriostatic drug with molecular formula C10H24N2O2.2HCl, which the findings say is used to make anti-tuberculosis medicines. It is a white crystalline powder made from ethambutol, the free base, an oily liquid. The investigation covers both forms. DGTR rejected requests to leave out the free base, noting that it has no independent use and must be converted into the hydrochloride, and that Lupin makes both. The findings classify the goods under HS code 2905 14 10, note the claim that they also come in under 2905 14 90, and call the classification indicative only. The duty table lists both tariff items.

The period of investigation was April 1, 2024 to March 31, 2025. By DG Systems data, imports were 16 MT in 2021-22, none in 2022-23 and 4 MT in 2023-24, then 122 MT in the period of investigation: 100 MT from China and 22 MT from Thailand. No other country supplied any. DGTR assessed the two countries' imports together. Wuhan Wuyao exported to India through two unrelated traders. DGTR set dumping margins of 30-40% for Wuhan Wuyao, 40-50% for other Chinese producers and 15-25% for Thailand, where no producer took part, and injury margins of 10-20%, 10-20% and 15-25%. It found the domestic industry made losses, with a negative return on capital employed, in the period of investigation.

DGTR recommends a duty for five years from the date of the Central Government's notification, equal to the lesser of the dumping and injury margins, as an amount in US$ per MT. It is USD 5,347 for Wuhan Wuyao Pharmaceutical Co. Limited and USD 7,234 for any other producer in China. It is USD 6,584 for goods originating in Thailand, exported from any country. Goods exported from China or Thailand that originate in any other country pay that exporting country's all-others rate: USD 7,234 or USD 6,584. Wuhan Wuyao's rate needs a commercial invoice carrying the declaration set out in the findings; without one, the all-others rate applies. On the domestic industry's figures, a duty of USD 5 per kg would add about ₹2.76 to a 10-tablet strip.

DGTR's preliminary findings of January 30, 2026 (Gazette CG-DL-E-02022026-269765) recommended a provisional anti-dumping duty, and DGTR sent them to the Ministry of Finance to consider an interim duty. The final findings do not say whether a provisional duty was imposed. These findings are a recommendation: by October 28, 2026, the Ministry of Finance had not notified the duty, and CBIC's list of 2026 anti-dumping notifications does not include it. An appeal lies before the Customs, Excise and Service Tax Appellate Tribunal.

**Issued by**: Directorate General of Trade Remedies, Department of Commerce, Ministry of Commerce & Industry

**Document**: Final Findings, Case No. AD(OI)-22/2025 (F. No. 6/25/2025-DGTR)

**Dated**: September 17, 2026

**Published**: Gazette of India, Extraordinary, Part I, Section 1, No. 254, September 17, 2026 (CG-DL-E-30092026-276628)

**Applies to**: Imports of ethambutol hydrochloride, and ethambutol in its free base form, from China and Thailand

**Tariff items in the duty table**: 2905 14 10 and 2905 14 90

**Recommended duty**: USD 5,347 or 7,234 per MT for China; USD 6,584 per MT for Thailand

**Duration**: Five years from the date of the Central Government's notification

**Takes effect**: Not yet: the Ministry of Finance had not notified the duty by October 28, 2026

**Preliminary findings**: January 30, 2026 (CG-DL-E-02022026-269765), recommending a provisional duty

**Period of investigation**: April 1, 2024 to March 31, 2025

**Imports in the period of investigation**: 122 MT: 100 MT from China and 22 MT from Thailand

**Domestic industry**: Lupin Limited

**Signed by**: Amitabh Kumar, Designated Authority

## Recommended anti-dumping duty

| S.No | Heading | Description | Country of origin | Country of export | Producer | Amount (US$/MT) |
|---|---|---|---|---|---|---|
| 1 | 2905 1410, 2905 1490 | "Ethambutol, ethambutol Hydrochloride" | China PR | Any | Wuhan Wuyao Pharmaceutical Co. Limited | 5,347 |
| 2 | do | do | China PR | Any | Any producer other than S. No. 1 | 7,234 |
| 3 | do | do | Any country other than China PR and Kingdom of Thailand | China PR | Any | 7,234 |
| 4 | do | do | Kingdom of Thailand | Any | Any | 6,584 |
| 5 | do | do | Any country other than China PR and Kingdom of Thailand | Kingdom of Thailand | Any | 6,584 |

[The final findings](https://files.indusdesk.com/dgtr/cases/ad-oi-22-2025/final-findings-2026-09-17.pdf) (PDF, 3.7 MB)

Source: [Gazette of India, CG-DL-E-30092026-276628](https://egazette.gov.in/WriteReadData/2026/276628.pdf).

Checked against the official copy on October 28, 2026.

- [DGTR guide](https://indusdesk.com/dgtr/)

- [All DGTR insights](https://indusdesk.com/dgtr/insights/)
